Addiction is not a failure of willpower and should not be reduced to a promise that one gummy, herb or short cleanse can “detox” the body. Substance-use disorders can involve withdrawal, overdose risk, mental-health symptoms, physical illness and social pressures that require coordinated care.
Treatment begins with assessment
A qualified professional considers:
- Substance or substances used.
- Amount, frequency and duration.
- Previous withdrawal or seizures.
- Other medicines and health conditions.
- Pregnancy.
- Depression, anxiety, trauma or psychosis.
- Overdose history.
- Housing and support.
The safest plan differs for alcohol, opioids, benzodiazepines, stimulants, cannabis and other substances.
Withdrawal can be dangerous
Alcohol and benzodiazepine withdrawal can become life-threatening. Opioid withdrawal is intensely distressing and relapse after reduced tolerance can increase overdose risk. Other withdrawal states can also require monitoring and symptom treatment.
People should not be told that a retail product makes unsupervised withdrawal safe.
Evidence-based care is broader than detoxification
Depending on the substance and person, care can include:
- Medically supervised withdrawal management.
- Approved medicines.
- Psychological therapies.
- Overdose-prevention planning.
- Treatment of physical and mental-health conditions.
- Family or social support.
- Continuing relapse-prevention care.
Completing withdrawal is not the same as completing treatment.
Recovery is not linear
Return to use can occur and should prompt review rather than shame. A safety plan should consider tolerance changes, overdose risk, triggers, medicines and rapid reconnection with care.
Marketing claims to avoid
Do not claim that a product:
- Cures addiction.
- Guarantees de-addiction.
- Prevents withdrawal.
- Replaces rehabilitation.
- Works for every substance.
- Removes toxins within a fixed time.
- Prevents relapse.
- Makes abrupt stopping safe.
Testimonials do not substitute for evidence.
The role of a wellness product
If a clinician considers any supportive wellness product, its role should be narrow, transparent and secondary to professional care. The exact ingredients, interactions and evidence must be reviewed.
It should never be used to:
- Delay emergency care.
- Replace prescribed addiction treatment.
- Encourage abrupt withdrawal.
- Conceal substance use from clinicians.
DetoX communication standard
DetoX should not be described as a de-addiction treatment unless its approved status and robust clinical evidence specifically support that claim. The safer approach is to focus on professional-care education and provide accurate ingredient and safety information without implying treatment.
When urgent help is needed
Seek emergency medical care for seizures, severe confusion, hallucinations, loss of consciousness, breathing difficulty, chest pain, suspected overdose, severe agitation or inability to stay safe.
References
- World Health Organization, clinical guidelines for withdrawal management and treatment of drug dependence: https://www.who.int/publications/
- National Institute on Drug Abuse, treatment and recovery resources: https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
- Ministry of Social Justice and Empowerment, Government of India, drug-demand reduction resources: https://socialjustice.gov.in/
Disclaimer
This article is general education and not an individual treatment plan. Addiction and withdrawal require qualified assessment. Urgent symptoms require emergency medical care.
